CellCept 250mg Capsule contains mycophenolate mofetil 250mg, an immunosuppressive medicine used in combination with other medicines to help prevent organ rejection following kidney, heart, and liver transplantation. CellCept is the reference brand of mycophenolate mofetil marketed by Roche/Genentech. It works by suppressing the activity of certain immune cells involved in the body’s rejection response.
CellCept 250mg is a prescription immunosuppressant and should be used only under the supervision of a transplant specialist or qualified healthcare professional. It is important to follow the prescribed regimen and monitoring schedule because immunosuppressive treatment can increase susceptibility to infections and requires ongoing medical monitoring.
CellCept 250mg Capsule is an oral formulation containing mycophenolate mofetil, an immunosuppressive medicine.
It is used together with other immunosuppressants and corticosteroids in transplant recipients to reduce the risk of the immune system attacking the transplanted organ.
Mycophenolate mofetil is converted in the body to mycophenolic acid (MPA), its active form. MPA inhibits inosine monophosphate dehydrogenase, an enzyme required for the proliferation of certain lymphocytes. This reduces the ability of immune cells to mount an immune response against the transplanted organ.
CellCept 250mg may be prescribed as part of an immunosuppressive regimen to help prevent rejection after:
It is generally used in combination with other transplant medicines rather than as a standalone treatment.
CellCept contains mycophenolate mofetil, which is converted to mycophenolic acid in the body.
Mycophenolic acid inhibits inosine monophosphate dehydrogenase (IMPDH), an enzyme involved in purine synthesis. Because certain lymphocytes depend heavily on this pathway for proliferation, inhibition reduces the proliferation of T and B lymphocytes and suppresses immune activity.
This immunosuppressive effect helps reduce the likelihood that the body will reject a transplanted organ.
The dose of CellCept is determined by the transplant team according to the type of transplant, other immunosuppressive medicines being used, kidney or liver function, tolerability and individual clinical factors.
CellCept should be taken exactly as prescribed. Do not change the dose, stop treatment or substitute another mycophenolate product without consulting the transplant specialist.
The 250mg capsule is a dosage form of mycophenolate mofetil and may be used as part of an individualized dosing regimen.
CellCept® is a branded product containing mycophenolate mofetil.
Mycophenolate mofetil 250mg manufactured by another pharmaceutical company may contain the same active ingredient and strength, but the manufacturer, formulation, inactive ingredients, packaging and regulatory authorization can differ.
Patients should not switch between formulations without guidance from their healthcare professional, particularly after transplantation.
Generic CellCept 250mg generally refers to an authorized mycophenolate mofetil 250mg product intended as an alternative to the CellCept brand.
Commercially relevant search relationships include:
CellCept 250mg → Mycophenolate Mofetil 250mg → Generic CellCept 250mg → Mycophenolate Mofetil 250mg Capsule → CellCept Alternative
Only describe a product as a generic equivalent where that status is supported by the applicable regulatory authorization.
CellCept 250mg Capsule and authorized mycophenolate mofetil alternatives are prescription medicines. Availability and dispensing requirements vary by country.
Customers searching for CellCept 250mg Capsule, Mycophenolate Mofetil 250mg, Generic CellCept 250mg, Mycophenolate Mofetil 250mg Capsule, Buy CellCept 250mg, CellCept 250mg Price, Generic Mycophenolate Mofetil and related terms can check availability through appropriately licensed pharmacies and pharmaceutical suppliers.
Prescription and importation requirements differ across the USA, UK, UAE/Dubai, Australia, Singapore, Thailand, China and Russia.
CellCept 250mg contains mycophenolate mofetil and is used with other medicines to help prevent rejection following kidney, heart or liver transplantation.
The generic name is mycophenolate mofetil 250mg.
Yes. CellCept is an immunosuppressive medicine that reduces immune-system activity involved in transplant rejection.
CellCept is a branded product containing mycophenolate mofetil. Authorized generic mycophenolate mofetil products contain the same active ingredient but may differ in manufacturer and formulation.
Yes. Mycophenolate mofetil is used as part of immunosuppressive therapy to prevent kidney-transplant rejection.
Yes. CellCept is also indicated as part of immunosuppressive therapy for prevention of rejection following heart and liver transplantation.
CellCept is prescription medicine. It should be purchased only from an appropriately licensed pharmacy or pharmaceutical supplier and used under medical supervision.
Potential adverse effects include diarrhea, nausea, vomiting, abdominal discomfort, headache and increased susceptibility to infections. Because CellCept suppresses the immune system, serious infections and other clinically important adverse effects can occur.
Yes. Patients taking mycophenolate mofetil generally require regular medical follow-up and laboratory monitoring as directed by their transplant team.
No. Do not stop CellCept or change the dose without medical advice. Inadequate immunosuppression can increase the risk of transplant rejection.
Mycophenolate mofetil can cause serious fetal harm and is subject to important pregnancy precautions. Patients who are pregnant, planning pregnancy or could become pregnant should discuss treatment and contraception requirements with their healthcare professional before taking CellCept.
Medical Disclaimer: This product information is provided for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. CellCept (mycophenolate mofetil) is a prescription immunosuppressant that requires specialist supervision and regular monitoring. It can cause serious adverse effects, including infections and fetal harm. Always follow the prescribing information for the specific product and consult your transplant specialist or qualified healthcare professional before starting, stopping or changing treatment.
Last Updated: August 23, 2026
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Only logged in customers who have purchased this product may leave a review.
Mycophenolate Mofetil · Immunosuppressive Agents
Reviews
There are no reviews yet.